assisTek Announces the Launch of Its Next Generation Platform for Clinical Trials
DOYLESTOWN, Pa., June 28, 2021 /PRNewswire/ -- assisTek, a boutique eSource company known for providing customized solutions to support clinical trial teams for two and a half decades, has announced the release of the next generation of its electronic clinical outcome assessment (eCOA) platform.
Fully cloud-based, the updated platform includes enhancements for patients, clinical teams, sponsors, and contract research organizations (CROs). It is electronic, secure, and in alignment with best practices for collection of clinical outcomes.
"At assisTek, we have a 25-year-long commitment to leadership in our field. Today, that means always striving to improve the patient experience and embracing the numerous benefits that the digital transformation of clinical research is delivering for all stakeholders," said Cindy Howry, assisTek President. "The release of our next generation platform is the latest step in that ongoing journey."
Designed with every consideration for the needs of today's clinical researchers and patients, the customizable and configurable assisTek platform supports engagement, compliance, accuracy, and efficiency at every step. Notable features and enhancements include . . .
assisTek is based in Doylestown, PA, and also maintains office in Scottsdale, AZ. To learn more, visit assisTek.com.
FOR MORE INFORMATION:
View original content to download multimedia:https://www.prnewswire.com/news-releases/assistek-announces-the-launch-of-its-next-generation-platform-for-clinical-trials-301320555.html